Treatment of SLE and Secondary Sjogrenand#8217;s Syndrome with Belimumab
Belimumab neutralizes the soluble form of B-cell activating factor and is
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Belimumab neutralizes the soluble form of B-cell activating factor and is
For authors and organisers
Find the right journal for your paper and submit your manuscript.